Welcome to our dedicated page for Global Cord Bloo SEC filings (Ticker: CORBF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Global Cord Blood Corporation (CORBF) provides key information to investors through its filings under the U.S. Securities Exchange Act of 1934. As a foreign private issuer, the company files annual reports on Form 20-F and furnishes current information on Form 6-K. One such Form 6-K explains that the Grand Court of the Cayman Islands appointed joint provisional liquidators for Global Cord Blood Corporation under Section 104(2) of the Companies Act of the Cayman Islands.
For CORBF, the most significant SEC filings relate to this provisional liquidation process. The Form 6-K details how joint provisional liquidators from Grant Thornton entities were appointed and how they periodically report to the Grand Court of the Cayman Islands. The filing specifically references the JPLs’ Fourteenth Report, furnished to the Court on December 1, 2025, and lists earlier report dates across several years.
On this SEC filings page, users can review Global Cord Blood Corporation’s Exchange Act disclosures, including Form 6-K reports that describe the status of the provisional liquidation and the role of the joint provisional liquidators. These documents help explain the legal context in which the company operates and provide a record of the court-supervised process.
Stock Titan enhances access to these filings by organizing them in one place and associating them with AI-powered tools that summarize lengthy documents and highlight key points. For a filer like Global Cord Blood Corporation, this can help readers quickly identify references to the Cayman Islands proceedings, the appointment of joint provisional liquidators, and the sequence of reports furnished to the Grand Court.
Global Cord Blood Corporation filed an update as a foreign private issuer describing the latest developments in its court-supervised provisional liquidation process in the Cayman Islands. The Grand Court previously appointed joint provisional liquidators (JPLs) for the company under the Cayman Companies Act.
On March 2, 2026, the JPLs submitted their fifteenth report to the Grand Court. The report is available to stakeholders on the company’s investor relations website and on Grant Thornton’s creditor update page. The filing also lists the dates of all prior JPL reports since October 2022, highlighting an ongoing series of structured status updates for creditors and other interested parties.
Global Cord Blood Corporation reports that its court-appointed joint provisional liquidators have submitted their fourteenth report to the Grand Court of the Cayman Islands. The liquidators were originally appointed on September 22, 2022 under the Cayman Islands Companies Act to oversee the Company’s affairs during provisional liquidation.
The new report, dated December 1, 2025, is available to the public on the Company’s investor relations website and on Grant Thornton’s creditor update page. The Company also notes that earlier reports from October 2022 through September 2025 remain accessible, providing an ongoing record of developments in the provisional liquidation process.